These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36968216)

  • 1. Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults.
    Zhang X; Zhao L; Ducatman A; Deng C; von Stackelberg KE; Danford CJ; Zhang X
    JHEP Rep; 2023 May; 5(5):100694. PubMed ID: 36968216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between per- and polyfluoroalkyl substances, liver function, and daily alcohol consumption in a sample of U.S. adults.
    Ma X; Fisher JA; VoPham T; Vasiliou V; Jones RR
    Environ Res; 2023 Oct; 235():116651. PubMed ID: 37451576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of per- and polyfluoroalkyl substances and nonalcoholic fatty liver disease in the United States adult population, 2003-2018.
    Momo HD; Alvarez CS; Purdue MP; Graubard BI; McGlynn KA
    Environ Epidemiol; 2024 Feb; 8(1):e284. PubMed ID: 38343734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin.
    Wang Y; Zhang J; Zhang J; Hou M; Kong L; Lin X; Xu J; Yan C; Lin F; Ke S
    Sci Total Environ; 2024 May; 925():171742. PubMed ID: 38494022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate concentrations and serum perfluoroalkyl and polyfluoroalkyl substance concentrations in adolescents and adults in the USA (National Health and Nutrition Examination Study 2003-16): an observational study.
    Zhang Y; Mustieles V; Wang YX; Sun Y; Agudelo J; Bibi Z; Torres N; Oulhote Y; Slitt A; Messerlian C
    Lancet Planet Health; 2023 Jun; 7(6):e449-e458. PubMed ID: 37286242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to per- and polyfluoroalkyl substance and metabolic syndrome: A nationally representative cross-sectional study from NHANES, 2003-2018.
    Wu M; Zhu Z; Wan R; Xu J
    Environ Pollut; 2024 Apr; 346():123615. PubMed ID: 38402937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort.
    Goodrich JA; Walker D; Lin X; Wang H; Lim T; McConnell R; Conti DV; Chatzi L; Setiawan VW
    JHEP Rep; 2022 Oct; 4(10):100550. PubMed ID: 36111068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of legacy and emerging per- and polyfluoroalkyl substances in the Anniston Community Health Surveys (ACHS I and ACHS II).
    Petriello MC; Mottaleb MA; Serio TC; Balyan B; Cave MC; Pavuk M; Birnbaum LS; Morris AJ
    Environ Int; 2022 Jan; 158():106907. PubMed ID: 34763231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to serum perfluoroalkyl substances and biomarkers of liver function: The Korean national environmental health survey 2015-2017.
    Kim OJ; Kim S; Park EY; Oh JK; Jung SK; Park S; Hong S; Jeon HL; Kim HJ; Park B; Park B; Kim S; Kim B
    Chemosphere; 2023 May; 322():138208. PubMed ID: 36822523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per- and polyfluoroalkyl substances in sera from children 3 to 11 years of age participating in the National Health and Nutrition Examination Survey 2013-2014.
    Ye X; Kato K; Wong LY; Jia T; Kalathil A; Latremouille J; Calafat AM
    Int J Hyg Environ Health; 2018 Jan; 221(1):9-16. PubMed ID: 28993126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach.
    Jin R; McConnell R; Catherine C; Xu S; Walker DI; Stratakis N; Jones DP; Miller GW; Peng C; Conti DV; Vos MB; Chatzi L
    Environ Int; 2020 Jan; 134():105220. PubMed ID: 31744629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of per- and polyfluoroalkyl substances with the antioxidant bilirubin across pregnancy.
    Taibl KR; Dunlop AL; Smith MR; Walker DI; Ryan PB; Panuwet P; Corwin EJ; Kannan K; Jones DP; Marsit CJ; Tan Y; Liang D; Eick SM; Barr DB
    Free Radic Biol Med; 2024 Oct; 223():184-192. PubMed ID: 39097204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to Per- and Polyfluoroalkyl Substances and Mortality in U.S. Adults: A Population-Based Cohort Study.
    Wen X; Wang M; Xu X; Li T
    Environ Health Perspect; 2022 Jun; 130(6):67007. PubMed ID: 35731224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case-cohort study of per- and polyfluoroalkyl substance concentrations and incident prostate cancer in the cancer prevention Study-II LifeLink cohort study.
    Troeschel AN; Teras LR; Hodge JM; Rodriguez J; Wang Y; Daniel J; Diver WR; Winquist A
    Environ Res; 2024 Oct; 259():119560. PubMed ID: 38971361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of per- and polyfluoroalkyl substances with hepatic steatosis and metabolic dysfunction-associated fatty liver disease among patients with acute coronary syndrome.
    Yang M; Su W; Li H; Li L; An Z; Xiao F; Liu Y; Zhang X; Liu X; Guo H; Li A
    Ecotoxicol Environ Saf; 2023 Oct; 264():115473. PubMed ID: 37722302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.